Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 2
Submit an article Journal homepage
223
Views
55
CrossRef citations to date
0
Altmetric
Original Article

The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis

David S. H. Bell Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama Medical School, Birmingham, Alabama, USACorrespondence[email protected]
,
Mary Ann Lukas GlaxoSmithKline Pharmaceuticals, Philadelphia, Pennsylvania, USA
,
Frederick K. Holdbrook GlaxoSmithKline Pharmaceuticals, Philadelphia, Pennsylvania, USA
&
Michael B. Fowler Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California, USA
Pages 287-296 | Accepted 18 Nov 2005, Published online: 04 Jan 2006

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Vincent Woo, Kim Connelly, Peter Lin & Philip McFarlane. (2019) The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes. Current Medical Research and Opinion 35:7, pages 1283-1295.
Read now
Arushi Thaper & Alexander Kulik. (2018) Rationale for administering beta-blocker therapy to patients undergoing coronary artery bypass surgery: a systematic review. Expert Opinion on Drug Safety 17:8, pages 805-813.
Read now
Andre Pascal Kengne, Anastase Dzudie & Eugene Sobngwi. (2008) Heart failure in sub-Saharan Africa: A literature review with emphasis on individuals with diabetes. Vascular Health and Risk Management 4:1, pages 123-130.
Read now
Klaus KA Witte & Andrew L Clark. (2008) Carvedilol in the treatment of elderly patients with chronic heart failure. Clinical Interventions in Aging 3:1, pages 55-70.
Read now
WH Wilson Tang. (2007) A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus. Vascular Health and Risk Management 3:5, pages 639-645.
Read now
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni & Barry J Materson. (2006) The Use of Metoprolol CR/XL in the Treatment of Patients with Diabetes and Chronic Heart Failure. Vascular Health and Risk Management 2:2, pages 139-144.
Read now

Articles from other publishers (49)

William Hinton, Abdus Samad Ansari, Martin B. Whyte, Andrew P. McGovern, Michael D. Feher, Neil Munro & Simon de Lusignan. (2022) Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies. Diabetes, Obesity and Metabolism 25:2, pages 501-515.
Crossref
Daniel Coutiño-Castelán, Arturo Abundes-Velasco, Félix Damas de los Santos, Eduardo A. Arias Sánchez, Celso Mendoza González, Arturo Méndez Ortiz, José L. Morales, José Luis Briseño de la Cruz, César Eduardo Hernández Fonseca, Piero Custodio Sánchez & Joel Rodriguez-Saldana. 2023. The Diabetes Textbook. The Diabetes Textbook 813 835 .
Sumant P. Radhoe, Jesse F. Veenis, Gerard C.M. Linssen, Chris Lee, Luc W.M. Eurlings, Hans Kragten, Nadea Y.Y. Al‐Windy, Aukje Spank, Stefan Koudstaal, Hans‐Peter Brunner‐La Rocca & Jasper J. Brugts. (2021) Diabetes and treatment of chronic heart failure in a large real‐world heart failure population. ESC Heart Failure 9:1, pages 353-362.
Crossref
David S.H. Bell & Edison Goncalves. (2021) Diabetogenic effects of cardioprotective drugs. Diabetes, Obesity and Metabolism 23:4, pages 877-885.
Crossref
Farshad Naghsh-Nilchi & Mahmoud Etebari. (2021) Attenuation of hyperinsulinemia-induced DNA damage of peripheral lymphocytes by carvedilol. Journal of Reports in Pharmaceutical Sciences 10:2, pages 265.
Crossref
Catrin Sohrabi, Bunny Saberwal, Wei-Yao Lim, Dimitris Tousoulis, Syed Ahsan & Nikolaos Papageorgiou. (2020) Heart Failure in Diabetes Mellitus: An Updated Review. Current Pharmaceutical Design 26:46, pages 5933-5952.
Crossref
Stephen F. Vatner, Jie Zhang, Marko Oydanich, Tolga Berkman, Rotem Naftalovich & Dorothy E. Vatner. (2020) Healthful aging mediated by inhibition of oxidative stress. Ageing Research Reviews 64, pages 101194.
Crossref
Javed Butler, James L. Januzzi & Julio Rosenstock. (2020) Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy. Diabetes, Obesity and Metabolism 22:8, pages 1243-1262.
Crossref
Hiroshi Ito. (2019) 7. Diabetes and Heart Failure: How to Treat Doubles Dangers7．糖尿病と心不全：その治療に迫る. Nihon Naika Gakkai Zasshi 108:9, pages 1902-1911.
Crossref
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, Larry A. Allen, Michael Chan, Akshay S. Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N. Kosiborod, Carolyn L. Lekavich, Rozalina G. McCoy, Robert J. Mentz & Ileana L. Piña. (2019) Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 140:7.
Crossref
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, Larry A. Allen, Michael Chan, Akshay S. Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N. Kosiborod, Carolyn L. Lekavich, Rozalina G. McCoy, Robert J. Mentz & Ileana L. PiÑa. (2019) Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure 25:8, pages 584-619.
Crossref
David S. H. Bell & Edison Goncalves. (2019) Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications. Diabetes, Obesity and Metabolism 21:6, pages 1277-1290.
Crossref
Helena C. KennyE. Dale Abel. (2019) Heart Failure in Type 2 Diabetes Mellitus. Circulation Research 124:1, pages 121-141.
Crossref
Daniel Coutiño-Castelán, Arturo Abundes-Velasco, Félix Damas de los Santos, Eduardo A. Arias Sánchez, Celso Mendoza González, Arturo Méndez Ortiz, José L. Morales, José Luis Briseño de la Cruz, César Eduardo Hernández Fonseca & Piero Custodio Sánchez. 2019. The Diabetes Textbook. The Diabetes Textbook 709 730 .
Anne Pernille Ofstad, Dan Atar, Lars Gullestad, Gisle Langslet & Odd Erik Johansen. (2018) The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions. Heart Failure Reviews 23:3, pages 303-323.
Crossref
Petar M. Seferović, Mark C. Petrie, Gerasimos S. Filippatos, Stefan D. Anker, Giuseppe Rosano, Johann Bauersachs, Walter J. Paulus, Michel Komajda, Francesco Cosentino, Rudolf A. de Boer, Dimitrios Farmakis, Wolfram Doehner, Ekaterini Lambrinou, Yuri Lopatin, Massimo F. Piepoli, Michael J. Theodorakis, Henrik Wiggers, John Lekakis, Alexandre Mebazaa, Mamas A. Mamas, Carsten Tschöpe, Arno W. Hoes, Jelena P. Seferović, Jennifer Logue, Theresa McDonagh, Jillian P. Riley, Ivan Milinković, Marija Polovina, Dirk J. van Veldhuisen, Mitja Lainscak, Aldo P. Maggioni, Frank Ruschitzka & John J.V. McMurray. (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 20:5, pages 853-872.
Crossref
Kim A. Connelly, Richard E. Gilbert & Peter Liu. (2018) Treatment of Diabetes in People With Heart Failure. Canadian Journal of Diabetes 42, pages S196-S200.
Crossref
Merlin C Thomas. (2018) Perspective Review : Type 2 Diabetes and Readmission for Heart Failure . Clinical Medicine Insights: Cardiology 12, pages 117954681877958.
Crossref
Csaba András Dézsi & Veronika Szentes. (2017) The Real Role of β-Blockers in Daily Cardiovascular Therapy. American Journal of Cardiovascular Drugs 17:5, pages 361-373.
Crossref
Qingtong WangYongming LiuQin FuBing XuYuan ZhangSungjin KimRuensern TanFederica BarbagalloToni WestEthan AndersonWei WeiE. Dale AbelYang K. Xiang. (2017) Inhibiting Insulin-Mediated β 2 -Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction . Circulation 135:1, pages 73-88.
Crossref
Pupalan IyngkaranSamia R. ToukhsatiMerlin C. ThomasMichael V. JelinekDavid L. HareJohn D. Horowitz. (2016) A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure. Clinical Medicine Insights: Cardiology 10, pages CMC.S38444.
Crossref
Björn Lemmer. 2016. Arzneiverordnungs-Report 2016. Arzneiverordnungs-Report 2016 391 397 .
Björn Lemmer. 2015. Arzneiverordnungs-Report 2015. Arzneiverordnungs-Report 2015 535 546 .
Björn Lemmer. 2014. Arzneiverordnungs- Report 2014. Arzneiverordnungs- Report 2014 529 539 .
. (2013) Traitement du diabète chez les personnes atteintes d'insuffisance cardiaque. Canadian Journal of Diabetes 37, pages S639.
Crossref
Jonathan G. Howlett & John C. MacFadyen. (2013) Traitement du diabète chez les personnes atteintes d'insuffisance cardiaque. Canadian Journal of Diabetes 37, pages S501-S503.
Crossref
. (2013) Treatment of Diabetes in People with Heart Failure. Canadian Journal of Diabetes 37, pages S328.
Crossref
Jonathan G. Howlett & John C. MacFadyen. (2013) Treatment of Diabetes in People with Heart Failure. Canadian Journal of Diabetes 37, pages S126-S128.
Crossref
Björn Lemmer. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013 473 484 .
Arzu Onay-BesikciElif SuzmecelikA. Tanju Ozcelikay. (2012) Carvedilol suppresses fatty acid oxidation and stimulates glycolysis in C2C12 cells. Canadian Journal of Physiology and Pharmacology 90:8, pages 1087-1093.
Crossref
John T. Parissis, Pinelopi Rafouli-Stergiou, Alexandre Mebazaa, Ignatios Ikonomidis, Vassiliki Bistola, Maria Nikolaou, Taly Meas, Juan Delgado, Fabio Vilas-Boas, Ioannis Paraskevaidis, Maria Anastasiou-Nana & Ferenc Follath. (2012) Acute heart failure in patients with diabetes mellitus: Clinical characteristics and predictors of in-hospital mortality. International Journal of Cardiology 157:1, pages 108-113.
Crossref
Ulrich Schwabe & Dieter PaffrathBjörn Lemmer. 2012. Arzneiverordnungs-Report 2012. Arzneiverordnungs-Report 2012 485 496 .
B.C. Flynn, W.J. Vernick & J.E. Ellis. (2011) β-Blockade in the perioperative management of the patient with cardiac disease undergoing non-cardiac surgery. British Journal of Anaesthesia 107, pages i3-i15.
Crossref
Björn Lemmer. 2011. Arzneiverordnungs-Report 2011. Arzneiverordnungs-Report 2011 479 490 .
Björn Lemmer. 2010. Arzneiverordnungs-Report 2010. Arzneiverordnungs-Report 2010 461 472 .
Usha Subramanian, Masoor Kamalesh, MʼHamed Temkit, George J. Eckert & Stephen Sawada. (2009) Do Cardioselective β-Adrenoceptor Antagonists Reduce Mortality in Diabetic Patients with Congestive Heart Failure?. American Journal Cardiovascular Drugs 9:4, pages 231-240.
Crossref
Björn Lemmer. 2009. Arzneiverordnungs-Report 2009. Arzneiverordnungs-Report 2009 433 445 .
David S.H. Bell. (2008) Diabetes: A Cardiac Condition Manifesting as Hyperglycemia. Endocrine Practice 14:7, pages 924-932.
Crossref
N. Danchin, A. Chaib, A. Lepillier & E. Durand. (2008) Les bêtabloquants restent précieux, mais…. Médecine des Maladies Métaboliques 2:2, pages 151-154.
Crossref
Björn Lemmer. 2008. Arzneiverordnungs-Report 2007. Arzneiverordnungs-Report 2007 459 471 .
Björn Lemmer. 2008. Arzneiverordnungs-Report 2008. Arzneiverordnungs-Report 2008 435 447 .
Masoor Kamalesh. (2007) Heart Failure in Diabetes and Related Conditions. Journal of Cardiac Failure 13:10, pages 861-873.
Crossref
David S.H. Bell. (2007) Heart Failure in the Diabetic Patient. Cardiology Clinics 25:4, pages 523-538.
Crossref
Donatella Del Sindaco, Giovanni Pulignano, Giovanni Cioffi, Luigi Tarantini, Andrea Di Lenarda, Stefania De Feo, Cristina Opasich, Giovanni Minardi, Ezio Giovannini & Francesco Leggio. (2007) Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure. Journal of Cardiovascular Medicine 8:9, pages 675-682.
Crossref
Sripal Bangalore, Franz H. Messerli, John B. Kostis & Carl J. Pepine. (2007) Cardiovascular Protection Using Beta-Blockers. Journal of the American College of Cardiology 50:7, pages 563-572.
Crossref
Steve Tsai & Marc Klapholz. (2007) Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure. Current Heart Failure Reports 4:2, pages 110-116.
Crossref
W. H. Wilson Tang. (2007) Glycemic control and treatment patterns in patients with heart failure. Current Cardiology Reports 9:3, pages 242-247.
Crossref
Björn Lemmer. 2007. Arzneiverordnungs-Report 2006. Arzneiverordnungs-Report 2006 499 511 .
Riham Zein Fardoun. (2006) Carvedilol versus Cardioselective β-Blockers for the Treatment of Hypertension in Patients with Type 2 Diabetes Mellitus. Pharmacotherapy 26:10, pages 1491-1500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.